Company Filing History:

45 out of 1,603

Sandoz Gmbh

1 out of 832,680

Other

patents

Years Active: 1976-1989

Loading Chart...

47 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 4870199 - Processes for the synthesis of diprotected (1989-09-26),

2. 4760065 - Trifluoromethyl substituted tetracyclic quinazolin-ones having (1988-07-26),

3. 4452787 - 1-Substituted tricyclic quinazolinones having biological activity as (1984-06-05),

4. 4451464 - Trifluoromethyl substituted tricyclic quinazolinones useful as (1984-05-29),

5. 4451448 - 1-Substituted tricyclic quinazolinones useful as tranquilizers (1984-05-29),

6. 4412952 - Process for 3-hydroxy benzodiazepinones (1983-11-01),

7. 4281131 - 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof (1981-07-28),

8. 4273930 - 4-Hydroxy-2-quinolinone-3-carboxylic acid esters (1981-06-16),

9. 4264602 - 4-Hydroxy-3-nitro-pyrido[2,3-B]pyridine-2(1H)-ones (1981-04-28),

10. 4221797 - Dihydroquinoline-one derivatives (1980-09-09),

11. 4192876 - 4-Hydroxy-3-nitro-quinoline-2(1H)-ones (1980-03-11),

12. 4190659 - Pharmaceutical preparation and use of (1980-02-26),

13. 4187309 - 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof (1980-02-05),

14. 4169893 - 4-Hydroxy-naphthpyridine-2(1H)-one-3-carboxylic acids and esters (1979-10-02),

15. 4160032 - Oxindoles as sleep-inducers (1979-07-03),

Title: Innovative Contributions of Goetz E Hardtmann in Pharmaceutical Chemistry

Introduction

Goetz E Hardtmann, based in Morristown, NJ, has made significant strides in the field of pharmaceutical chemistry. With an impressive portfolio of 47 patents, he has consistently contributed to advancements that enhance the synthesis of various chemical compounds, particularly those beneficial in the treatment of central nervous system disorders.

Latest Patents

Among his latest innovations are processes for the synthesis of diprotected compounds. Notably, he has developed a method for synthesizing compounds of the formula involving R[R*,S*] enantiomeric forms, which include hydroxy group-protecting groups. Furthermore, his work on trifluoromethyl substituted tetracyclic quinazolin-ones highlights compounds that possess tranquilizing effects, making them potentially useful as CNS agents.

Career Highlights

Throughout his career, Goetz E Hardtmann has been affiliated with renowned organizations such as Sandoz GmbH and Sandoz Pharmaceutical Corporation. His role in these companies has enabled him to focus on the development of novel chemical processes and intermediates that are critical in the pharmaceutical industry.

Collaborations

While working in the industry, Goetz collaborated with esteemed professionals, including Gary Mark Coppola and William J Houlihan. These collaborations have fostered a rich environment for innovation and have allowed for the exchange of ideas that push the boundaries of pharmaceutical research.

Conclusion

Goetz E Hardtmann continues to be a prominent figure in the realm of pharmaceutical innovations. His extensive patent portfolio and collaborative efforts underscore his commitment to advancing the field and improving therapeutic options for patients in need.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.